TrialNPJ primary care respiratory medicine2016

The effect of umeclidinium added to inhaled corticosteroid/long-acting β2-agonist in patients with symptomatic COPD: a randomised, double-blind, parallel-group study.

Ana R Sousa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.